Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute mountain sickness score and hypoxemia.

M M Hussain1, M Aslam, Z Khan

  • 1High Altitude Medical Research Cell (HALMARC), Army Medical College, Rawalpindi.

JPMA. the Journal of the Pakistan Medical Association
|July 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

Halide Double Perovskites: Insights into Structure, Defects, and Luminescence.

ACS applied materials & interfaces·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026

Acute mountain sickness (AMS) severity is linked to hypoxemia. Combined acetazolamide-dexamethasone treatment effectively prevents AMS symptoms during rapid high-altitude ascent.

Area of Science:

  • Altitude Medicine
  • Physiology
  • Pharmacology

Background:

  • Hypobaric hypoxia causes hypoxemia, the primary driver of acute mountain sickness (AMS).
  • Gradual ascent prevents AMS, but rapid ascent is common in military and climbing operations.
  • Current AMS prophylaxis recommendations are often impractical for rapid ascent scenarios.

Purpose of the Study:

  • To quantify the relationship between AMS and hypoxemia.
  • To evaluate the efficacy of acetazolamide-dexamethasone chemoprophylaxis for acute ascent.
  • To assess AMS prevention strategies for rapid high-altitude exposure.

Main Methods:

  • 24 lowlander males ascended to 4578m in one day.
  • Participants received placebo, acetazolamide, dexamethasone, or combined therapy twice daily for 5 days.

Related Experiment Videos

  • AMS symptoms (ESQ), and blood gases (PaO2, SaO2, PaCO2) were measured post-ascent.

    • Main Results:

    • Combined acetazolamide-dexamethasone significantly reduced AMS-C and AMS-R scores.
    • Acetazolamide caused mild diuresis; dexamethasone reduced headache severity.
    • No volunteers on combined therapy reported headache, dyspnea, or irritability.

    Conclusions:

    • AMS severity is strongly correlated with hypoxemia.
    • Combined acetazolamide-dexamethasone therapy shows significant promise for preventing AMS during rapid ascent.
    • This combination may offer effective prophylaxis against acute mountain sickness.